GAF Healthcare
Specialty Overview

Best Hospitals for Nasopharyngeal Cancer Treatment in Chennai, India

10 cancer care hospitals in our India network are listed in Chennai, accredited by JCI, NABH, NABL, with 4,235 beds combined.

10
Hospitals Listed
1
City
4.5
Avg. Rating
3
Accreditation Types
The Short Answer

This page lists the cancer care hospitals in our directory offering Nasopharyngeal Cancer Treatment in Chennai, India, including Apollo Athenaa Women's Cancer Centre, Apollo Proton Cancer Centre, Apollo Hospitals, Greams Road, Gleneagles Global Hospital and others. Each listing links through to the hospital's full profile page.

Including:🇮🇳 Apollo Athenaa Women's Cancer Centre🇮🇳 Apollo Proton Cancer Centre🇮🇳 Apollo Hospitals, Greams Road

Ask us about nasopharyngeal cancer treatment in Chennai, India

Share a few details and our care coordination team will get back to you with next steps.

Compare 10 accredited hospitals for Cancer Care in Chennai, India

Apollo Athenaa Women's Cancer Centre Featured
Starting from$1,000

🇮🇳 Apollo Athenaa Women's Cancer Centre

Chennai, India 4.9 (47 reviews) 50 beds
Why consider this hospital?
4.9/5 rating from 47 reviewsAccredited by JCI, NABH50 beds
Specialties & Accreditation
Medical OncologyRadiation OncologySurgical Oncology
Accredited by JCI, NABH

Patients considering nasopharyngeal cancer treatment can be cared for by Apollo Athenaa Women's Cancer Centre's care team in Chennai, India, from initial consultation through recovery. Apollo Athenaa Women's Cancer Centre, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

4.9/5
Rating
2025
Established
50
Beds
Chennai, India
Location
Enquire NowView Profile
Apollo Proton Cancer Centre
Starting from$1,000

🇮🇳 Apollo Proton Cancer Centre

Chennai, India 4.8 (213 reviews) 150 beds
Why consider this hospital?
4.8/5 rating from 213 reviewsAccredited by NABH150 beds
Specialties & Accreditation
Medical OncologyRadiation OncologySurgical OncologyNeurosurgery
Accredited by NABH

Patients considering nasopharyngeal cancer treatment can be cared for by Apollo Proton Cancer Centre's care team in Chennai, India, from initial consultation through recovery. Apollo Proton Cancer Centre, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

4.8/5
Rating
2019
Established
150
Beds
Chennai, India
Location
Enquire NowView Profile
Apollo Hospitals, Greams Road
Starting from$1,000

🇮🇳 Apollo Hospitals, Greams Road

Chennai, India 4.7 (125 reviews) 560 beds
Why consider this hospital?
4.7/5 rating from 125 reviewsAccredited by JCI, NABH560 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering nasopharyngeal cancer treatment can be cared for by Apollo Hospitals, Greams Road's care team in Chennai, India, from initial consultation through recovery. Apollo Hospitals, Greams Road, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

4.7/5
Rating
1983
Established
560
Beds
Chennai, India
Location
Enquire NowView Profile
Gleneagles Global Hospital
Starting from$1,000

🇮🇳 Gleneagles Global Hospital

Chennai, India 4.7 (112 reviews) 1,000 beds
Why consider this hospital?
4.7/5 rating from 112 reviewsAccredited by NABH, JCI1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by NABH, JCI

Patients considering nasopharyngeal cancer treatment can be cared for by Gleneagles Global Hospital's care team in Chennai, India, from initial consultation through recovery. Gleneagles Global Hospital, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

4.7/5
Rating
1999
Established
1,000
Beds
Chennai, India
Location
Enquire NowView Profile
Dr. Rela Institute and Medical Centre
Starting from$1,000

🇮🇳 Dr. Rela Institute and Medical Centre

Chennai, India 4.7 (108 reviews) 450 beds
Why consider this hospital?
4.7/5 rating from 108 reviewsAccredited by NABH, NABL450 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by NABH, NABL

Patients considering nasopharyngeal cancer treatment can be cared for by Dr. Rela Institute and Medical Centre's care team in Chennai, India, from initial consultation through recovery. Dr. Rela Institute and Medical Centre, accredited by NABH, NABL, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

4.7/5
Rating
2018
Established
450
Beds
Chennai, India
Location
Enquire NowView Profile
SIMS Hospital
Starting from$1,000

🇮🇳 SIMS Hospital

Chennai, India 4.6 (20 reviews) 345 beds
Why consider this hospital?
4.6/5 rating from 20 reviewsAccredited by NABH, JCI345 beds
Specialties & Accreditation
Cardiac SurgeryNeurosciencesTransplantOrthopedicsGastroenterology
Accredited by NABH, JCI

Patients considering nasopharyngeal cancer treatment can be cared for by SIMS Hospital's care team in Chennai, India, from initial consultation through recovery. SIMS Hospital, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

4.6/5
Rating
1970
Established
345
Beds
Chennai, India
Location
Enquire NowView Profile
Sankara Nethralaya
Starting from$1,000

🇮🇳 Sankara Nethralaya

Nungambakkam, Chennai, India 4.4 (220 reviews) 200 beds
Why consider this hospital?
4.4/5 rating from 220 reviewsAccredited by NABH, NABL200 beds
Specialties & Accreditation
OphthalmologyRetina SurgeryCornea TransplantGlaucomaPediatric Ophthalmology
Accredited by NABH, NABL

Patients considering nasopharyngeal cancer treatment can be cared for by Sankara Nethralaya's care team in Nungambakkam, Chennai, India, from initial consultation through recovery. Sankara Nethralaya, accredited by NABH, NABL, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

4.4/5
Rating
1978
Established
200
Beds
Nungambakkam, Chennai, India
Location
Enquire NowView Profile
Apollo First Med Hospitals, Kilpauk
Starting from$1,000

🇮🇳 Apollo First Med Hospitals, Kilpauk

Kilpauk, Chennai, India 4.4 (76 reviews) 80 beds
Why consider this hospital?
4.4/5 rating from 76 reviewsAccredited by NABH, JCI80 beds
Specialties & Accreditation
Cardiac SciencesOrthopedicsNeurologyOncologyGastroenterology
Accredited by NABH, JCI

Patients considering nasopharyngeal cancer treatment can be cared for by Apollo First Med Hospitals, Kilpauk's care team in Kilpauk, Chennai, India, from initial consultation through recovery. Apollo First Med Hospitals, Kilpauk, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

4.4/5
Rating
2002
Established
80
Beds
Kilpauk, Chennai, India
Location
Enquire NowView Profile
MIOT International
Starting from$1,000

🇮🇳 MIOT International

Manapakkam, Chennai, India 4.4 (200 reviews) 1,000 beds
Why consider this hospital?
4.4/5 rating from 200 reviewsAccredited by NABH, NABL, JCI1,000 beds
Specialties & Accreditation
OrthopedicsCardiac SurgeryNeurosciencesTransplantOncology
Accredited by NABH, NABL, JCI

Patients considering nasopharyngeal cancer treatment can be cared for by MIOT International's care team in Manapakkam, Chennai, India, from initial consultation through recovery. MIOT International, accredited by NABH, NABL, JCI, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

4.4/5
Rating
1999
Established
1,000
Beds
Manapakkam, Chennai, India
Location
Enquire NowView Profile
MGM Healthcare
Starting from$1,000

🇮🇳 MGM Healthcare

Chennai, India 3.7 (34 reviews) 400 beds
Why consider this hospital?
3.7/5 rating from 34 reviewsAccredited by NABH, JCI400 bedsHas a dedicated Cancer Care department
Specialties & Accreditation
Cancer CareCardiac SurgeryNeurosciencesTransplantOrthopedics
Accredited by NABH, JCI

Patients considering nasopharyngeal cancer treatment can be cared for by MGM Healthcare's Cancer Care department in Chennai, India, from initial consultation through recovery. MGM Healthcare, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing nasopharyngeal cancer treatment.

3.7/5
Rating
1970
Established
400
Beds
Chennai, India
Location
Enquire NowView Profile
Our Methodology

How we selected these hospitals

A hospital appears on this page when Cancer Care is among its listed specialties and it is located in Chennai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Nasopharyngeal Cancer Treatment in Chennai, India?

Choosing the right hospital for nasopharyngeal cancer treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include cancer care rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Nasopharyngeal Cancer Treatment

Nasopharyngeal cancer (NPC) is a malignancy arising from the epithelial lining of the nasopharynx, requiring a highly specialized multimodal approach combining intensity-modulated radiation therapy (IMRT), platinum-based chemotherapy, and—where indicated—targeted or immunotherapy agents.

7–21 days (varies by treatment phase: induction chemotherapy admissions average 3–5 days per cycle; concurrent chemoradiation is largely outpatient but may require 7–14 days of inpatient monitoring for toxicity management)
Hospital Stay
6–8 weeks (after completion of the primary chemoradiation course, patients typically require 4–6 weeks of local recovery and acute toxicity resolution before they are cleared for long-haul international flight; patients undergoing adjuvant immunotherapy may need to remain in-country for up to 8 weeks for the initial cycles)
Total Stay in Country (Fit-to-Fly)
72–90% (five-year overall survival for Stage I–III locoregional NPC; Stage I approaches 90%+; Stage IVA/B approximately 65–72% with modern chemoimmunotherapy protocols)
Success Rate

Clinical Overview

  • Nasopharyngeal carcinoma originates in the mucosal epithelium of the nasopharynx, the air-filled space behind the nasal cavity at the skull base.
  • The World Health Organization classifies NPC into three histological subtypes: Type I (keratinizing squamous cell carcinoma), Type II (non-keratinizing differentiated), and Type III (undifferentiated or lymphoepithelioma-like), with Type III being the most prevalent globally and most strongly associated with Epstein-Barr virus (EBV) infection.
  • Because the nasopharynx is anatomically adjacent to critical structures—the cavernous sinus, cranial nerves III through VI, the internal carotid artery, and the cervical lymphatic chains—tumor extension can cause epistaxis, unilateral serous otitis media, cranial nerve palsies, trismus, and cervical lymphadenopathy.
Full details →

Who is a Candidate?

  • ELIGIBLE PATIENTS:
  • Histologically confirmed NPC (biopsy of primary lesion or involved lymph node with pathology review)
  • Any AJCC 8th Edition stage (Stage I through IVB) considered for curative-intent treatment; Stage IVC (distant metastatic) considered for palliative or systemic intent
  • ECOG Performance Status 0–2 (adequate functional reserve for chemoradiation or systemic therapy)
  • +20 more

Treatment Options & Approaches

  • STANDARD CURATIVE-INTENT CHEMORADIATION (Stage II–IVB): The backbone of NPC treatment is concurrent cisplatin (40 mg/m² weekly or 100 mg/m² every 3 weeks) combined with intensity-modulated radiation therapy (IMRT) delivering 70 Gy in 33–35 fractions to the gross tumor volume (GTV), with sequential dose painting to elective nodal regions at 54–63 Gy.
  • Daily IGRT (cone-beam CT verification) ensures sub-millimeter positioning accuracy critical at the skull base.
  • Volumetric-modulated arc therapy (VMAT) is a widely used IMRT delivery technique that reduces treatment time per fraction while maintaining dosimetric precision.

Recovery

  • PRE-ARRIVAL (2–4 WEEKS BEFORE DEPARTURE):

Risks to be aware of

  • Nasopharyngeal cancer treatment carries a well-characterized spectrum of acute and late toxicities that patients must understand prior to initiating therapy.
  • Acute toxicities during chemoradiation include Grade 3–4 oral mucositis (occurring in 40–70% of patients), severe dysphagia requiring temporary enteral nutrition (20–40%), radiation dermatitis of the face and neck, nephrotoxicity and hypomagnesemia from cisplatin (requiring vigilant renal monitoring and electrolyte replacement), myelosuppression (requiring growth factor support and dose modifications), and fatigue.
Full details →

Why GAF Healthcare

  • GAF Healthcare provides a fully integrated, non-medical support system designed to eliminate logistical friction for international NPC patients and their families throughout the treatment journey.

Cost Range for Related Procedures

Cancer Surgery$4,000–$15,000
Chemotherapy$1,000–$4,000
Radiation Therapy$3,500–$10,000
Get a personalised estimate with our cost calculator →

Common questions about Nasopharyngeal Cancer Treatment

What is the cost of Nasopharyngeal Cancer Treatment in India compared to the UAE?
The total cost of a complete nasopharyngeal cancer treatment program—including induction chemotherapy (if indicated), concurrent chemoradiation (IMRT + cisplatin-based chemotherapy), all inpatient admissions, standard supportive medications, and routine monitoring investigations—typically ranges from $7,000 to $18,000 USD at top NABH- and JCI-accredited centers in India (including institutions such as Tata Memorial Hospital Mumbai, Apollo Proton Cancer Centre Chennai, Rajiv Gandhi Cancer Institute New Delhi, and Fortis Memorial Research Institute Gurgaon). The equivalent program at JCI- and DHA/DOH-accredited hospitals in the UAE (Cleveland Clinic Abu Dhabi, Mediclinic City Hospital Dubai, American Hospital Dubai) typically ranges from $18,000 to $42,000 USD—reflecting premium infrastructure, luxury patient experience, and higher operational costs. India is therefore approximately 55–65% less expensive than the UAE for equivalent clinical protocols. Both destinations deliver the same evidence-based treatment standards (NCCN/ESMO-aligned IMRT + cisplatin-based chemoradiation, plasma EBV DNA monitoring, MDT tumor board evaluation). If proton beam therapy is required—available at Apollo Proton Cancer Centre in Chennai and select UAE facilities—add approximately $15,000–$25,000 (India) or $30,000–$50,000 (UAE) to these base costs. GAF Healthcare provides itemized, all-inclusive cost estimates within 48–72 hours of receiving the patient's staging reports, with no hidden charges.
How long do I need to stay in the country before I am fit to fly home after Nasopharyngeal Cancer Treatment?
The minimum recommended in-country stay before international flight clearance is 6 to 8 weeks after completion of the primary concurrent chemoradiation course. A full NPC treatment program (induction chemotherapy + concurrent chemoradiation) requires approximately 12–15 weeks in-country if all phases are completed consecutively. Here is a practical breakdown: Induction chemotherapy alone (3 cycles of gemcitabine-cisplatin, if indicated) requires approximately 7–8 weeks in-country per phase, with short returns home possible between cycles if the patient's home-country oncologist can administer subsequent cycles. The concurrent chemoradiation phase (7 weeks of daily radiation, Monday–Friday) is continuous and cannot be interrupted; patients must remain in-country for the full duration. After the last radiation fraction, patients typically require a further 4–6 weeks of local recovery before acute toxicities (mucositis, dysphagia, fatigue) resolve sufficiently for safe air travel. At the 6-week post-CCRT mark, the treating team performs clinical review and, where appropriate, initial response MRI or plasma EBV DNA assessment. Fit-to-fly clearance is issued individually based on: (a) absence of uncontrolled acute toxicity, (b) adequate oral or enteral nutritional status, (c) no active infection or unresolved hematological suppression, and (d) no clinical evidence of rapid disease progression requiring immediate intervention. Patients commencing adjuvant immunotherapy (PD-1 inhibitors, 3-weekly cycles) should remain for the first 1–2 cycles to ensure no severe immune-related adverse events (irAEs) before traveling. GAF Healthcare coordinates all fit-to-fly assessments and provides formal medical documentation for airline travel insurance claims and airline medical clearance processes.
What is the success rate of Nasopharyngeal Cancer Treatment?
Nasopharyngeal carcinoma is one of the more treatment-responsive head and neck cancers, particularly for locoregional disease, owing to its high radiosensitivity and—in EBV-positive cases—sensitivity to immunotherapy. Five-year overall survival rates by AJCC 8th Edition stage, based on contemporary IMRT-era data from high-volume centers, are as follows: Stage I: approximately 90–95%; Stage II: approximately 85–90%; Stage III: approximately 78–85%; Stage IVA (T4 or N3, non-metastatic): approximately 65–75%; Stage IVB (M1, distant metastatic): approximately 30–40% at 3 years with modern chemoimmunotherapy (gemcitabine-cisplatin + camrelizumab or tislelizumab, per CAPTAIN-1 and JUPITER-02 trial data). Plasma EBV DNA clearance at week 8–12 post-CCRT is the strongest validated prognostic biomarker: patients achieving undetectable EBV DNA have a 3-year failure-free survival exceeding 88%, compared to approximately 47% for those with persistent EBV DNA elevation (Sun et al., NEJM 2023). At GAF Healthcare's partner institutions—which include centers with annual NPC case volumes exceeding 200–400 new patients—outcomes are consistent with or superior to these published benchmarks due to case volume, protocol standardization, and dedicated skull base oncology MDT structures. The success of treatment also depends on consistent follow-up surveillance, which GAF Healthcare facilitates remotely after the patient returns home through telemedicine and coordinated reporting with the local oncologist.

Related pages

How GAF Healthcare Assists in Choosing the Best Hospital for Nasopharyngeal Cancer Treatment in Chennai, India

Discover the Top Hospitals for Nasopharyngeal Cancer Treatment in Chennai, India

This page lists 10 accredited cancer care hospitals in Chennai, India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about nasopharyngeal cancer treatment in Chennai, India

How many cancer care hospitals are listed in Chennai, India?
10 hospitals in our Chennai, India directory are currently listed for cancer care including Nasopharyngeal Cancer Treatment.
How do you choose which hospitals to list?
A hospital appears on this page when Cancer Care is among its listed specialties and it is located in Chennai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there cancer care hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, NABL — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for nasopharyngeal cancer treatment?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about nasopharyngeal cancer treatment in Chennai, India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for nasopharyngeal cancer treatment in Chennai, India.

Contact us to report an inaccuracy on this page.

WhatsApp Us